An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China
Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
London Health Sciences Centre, London, Ontario, Canada
KoreaUniversity Guro Hospital, Seoul, Guro-ku, Korea, Republic of
Rainbow Babies and Children's Hospital, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
MetroHealth System, Case CTSA, Cleveland, Ohio, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Peking University First Hospital, Beijing, Beijing, China
Faculty of Medicine, Cairo, Shebin El-kom, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.